Abstract:Introduction Atrial fibrosis is a major remodelling process in atrial fibrillation (AF). The lack of clinically effective drug targets, due to insufficient understanding of the mechanisms of cardiac fibrosis, hampers the treatment of AF. Orphan nuclear receptor subfamily 4 group A member 1 (NR4A1) is linked to fibrotic disease in multiple organs, however, its role in cardiac fibrosis and AF is yet to be demonstrated. Recent transcriptomic profiling revealed that NR4A1 expression is downregulated in human atrial cardiac fibroblasts (ACFs) in the presence of persistent AF. However, its mechanistic role in atrial fibrogenesis and AF is unknown. Purpose To investigate the expression profile and function of NR4A1 in human ACFs and provide insights into the role of NR4A1 in the context of persistent AF. Methods Human ACFs were isolated (enzymatic digestion) from right and left atrial appendages of 24 patients with persistent AF and controls in sinus rhythm (SR), who had elective heart surgery. NR4A1 knockdown in ACFs was achieved using NR4A1-siRNA. Gene and protein expression were determined by qPCR and western blot respectively, while BrdU assay and scratch assay were used to evaluate cell proliferation and migration. Atrial fibroblasts subpopulations were identified by single-nucleus RNA-sequencing. Subcellular localisation of NR4A1 was assessed by immunostaining, analysed by ImageJ. Results Validation of RNA-sequencing data confirmed a reduction of NR4A1 gene expression in human ACFs in persistent AF by 25% (p=0.029, Fig. 1A) and the NR4A1 predominant abundance in one of three identified subclusters of human ACFs (NR4A1+NAMPT+). The siRNA-mediated knockdown of NR4A1 in ACFs suppressed gene and protein expression of important component of extracellular matrix collagen-1 (Fig. 1B and Fig. 1C) and fibronectin protein (but not mRNA). The NR4A1-deficient cells also had decreased alpha-smooth muscle actin (αSMA) protein and gene expression (Fig. 1D and Fig. 1E), reduced periostin gene expression in the absence of changes in its protein. Furthermore, the NR4A1-deficiency reduced proliferation (by 18%, p=0.005, Fig. 1F) and accelerated migration (p=0.019, Fig. 1G) of human ACFs. These effects were independent of TGF-β1 stimulation, unlike reported in rat neonatal cardiac and dermal fibroblasts. Despite decreased NR4A1 gene expression, patients with AF had doubled NR4A1 protein levels compared to SR-ACFs (p=0.049, Fig. 2A). This was associated with abnormal 1.8-fold increase in the receptor subcellular localisation (p=0.032, Fig. 2B and Fig. 2C), as opposed to the physiological nuclear localisation observed in ACFs in the absence of AF. Conclusion While under physiological conditions, NR4A1 potently activates profibrotic processes in human ACFs, persistent AF patients have increased but abnormally distributed NR4A1 protein in atrial fibroblasts, whose consequences are yet to be determined in order to develop new therapies for AF.Figure 1Figure 2

Serum Levels of Nicotinamide-Adenine Dinucleotide Phosphate Oxidase 4 Are Associated with Non-Valvular Atrial Fibrillation

NOX4-Dependent Hydrogen Peroxide Overproduction in Human Atrial Fibrillation and HL-1 Atrial Cells: Relationship to Hypertension.

Manganese Superoxide Dismutase as a Novel Oxidative Stress Biomarker for Predicting Paroxysmal Atrial Fibrillation

Eosinophils in Patients with Lone Atrial Fibrillation

Plasma Oxidative Stress and Inflammatory Biomarkers Are Associated with the Sizes of the Left Atrium and Pulmonary Vein in Atrial Fibrillation Patients.

Relationship between Serum HMGB1 and Oxidative Stress in Patients with Atrial Fibrillation

Serum N-Acetylneuraminic Acid is Associated with Atrial Fibrillation and Left Atrial Enlargement

Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension.

Increased serum HMGB1 is related to oxidative stress in patients with atrial fibrillation.

Expression of NADPH oxidase in heart failure patients and its relationship with myocardium fibrosis

NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation

Relationship between NADPH oxidase of peripheral blood mononuclear cells and left ventricular remodeling in patients with acute myocardial infarction

Modulation of NOX2 causes obesity-mediated atrial fibrillation

The Correlation of Inflammation, Oxidative Stress, and Hippocampal Perfusion in Patients with Atrial Fibrillation

The role of IL-6, IL-10, TNF-α and PD-1 expression on CD4 T cells in atrial fibrillation

Changes of Endothelial Function Indices and Their Relation to Platelet Activation in Idiopathic Atrial Fibrillation

NOX4 Expression and Distal Arteriolar Remodeling Correlate with Pulmonary Hypertension in COPD

Abstract 14496: NOX2 Inhibition Reverses Atrial Remodeling Caused by Increased Oxidative Stress and Reduces AF in Diet Induced Obese Mice

Investigating the role of an orphan nuclear receptor NR4A1 in atrial fibrillation

Plasma myeloperoxidase: association with atrial fibrillation progression and recurrence after catheter ablation

Abstract 14079: Inhibition of NOX2 Prevents Obesity-Mediated Atrial Fibrillation